menuMenu
  •  PROFESIONALES DE LA SALUD
  • languageEN TODO EL MUNDO
  • callCONTÁCTANOS
  • ACERCA DE NOSOTROS
    close
    • Acerca de nosotros
    • Responsabilidad Corporativa
    • Nuestro trabajo
      • – Resistencia antimicrobiana
      • – Diabetes
      • – Hepatitis C
      • – VIH
      • – Oncología
      • – Vacunas
    • Liderazgo
    • Acceso a los medicamentos en investigación
    • Cómo operamos
    • Nuestra historia
    • Nuestra gente
  • INVENTAR PARA LA VIDA 
  • Investigación
  • LICENCIA
  • PRENSA 
  • CARRERAS
  • ACERCA DE NOSOTROS navigate_next
    • Responsabilidad Corporativa
    • Nuestro trabajonavigate_next
      • Resistencia antimicrobiana
      • Diabetes
      • Hepatitis C
      • VIH
      • Oncología
      • Vacunas
    • Liderazgo
    • Acceso a los medicamentos en investigación
    • Cómo operamos
    • Nuestra historia
    • Nuestra gente
  • INVENTAR PARA LA VIDA 
  • INVESTIGACIÓN 
  • LICENCIA 
  • PRENSA 
  • CARRERAS 

Nuestro trabajo en la diabetes

 
 
 
 

.

 
 

Diabetes tipo 2: un enfoque en HbA1c

El Dr. Sam Engel habla sobre la diabetes tipo 2 y la importancia del logro de los objetivos de HbA1c.

 
 

Viviendo Con Diabetes Tipo 2

"Siempre me consideré una persona muy sana. A veces todavía me sorprendo cuando pienso en mi diagnóstico."

— Karen Bachert, Especialista Senior en Gestión de Cuentas de TI

 
 

Honrando nuestras diferencias

Este mes de septiembre, MSD celebra su segundo mes anual de la Experiencia de inclusión y diversidad global, con programas especiales, charlas y exposiciones.

 
 

Diversidad e inclusión: bueno para los negocios

Por Celeste Warren, vicepresidenta de Recursos Humanos y directora principal de diversidad, MSD

 
 

Siempre hemos estado y siempre estaremos inventando, y lo hacemos con el único propósito más grande: la vida.

 
 

@MSDLatAm
OTROS SITIOS MSD
 
 

We remain dedicated to helping those impacted by #HurricaneMaria and the #MexicoEarthquake. https://t.co/0gxTche5ia

We’re working to reduce our waste footprint to create a future w/ more beautiful land & less landfills:… https://t.co/SQknCRVUDu

“What a great day! I am a proud partner of Your Cancer Game Plan and have more tips to share with you. Visit:… https://t.co/HKSBq99bDz

    • Síguenos:
 
 
  • OTHER MSD SITES
    MSD para Madres
  • Responsabilidad Corporativa
    Sitio web de MSDResponsabilidad Corporativa chevron_right
  • Salud Animal
  • Manuales MSD
  • UNIVADIS® (un servicio de MSD)
 
 
 

Derechos reservados ©2009-2018 Merck Sharp & Dohme Corp. Una subsidiaria de Merck & Co., Inc., Kenilworth, NJ, USA. Todos los derechos reservados.

El mantenimiento de este sitio es responsabilidad de Merck Sharp & Dohme Corp., una subsidiaria de Merck & Co., Inc., Kenilworth, NJ, USA. SA.

  • Política de Privacidad
  • Aviso de privacidad
  • Términos y condiciones de uso
  • Preferencias de cookie
Image: Circle Close Icon

Forward-Looking Statement ×
 

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.